These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25789685)

  • 21. Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors.
    Bartley AN; Rashid A; Fournier KF; Abraham SC
    Hum Pathol; 2011 Oct; 42(10):1420-9. PubMed ID: 21419473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucin-producing carcinoma of the prostate: review of 88 cases.
    Saito S; Iwaki H
    Urology; 1999 Jul; 54(1):141-4. PubMed ID: 10414741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary colorectal signet-ring cell carcinoma: clinicopathological features and postoperative survival.
    Mizushima T; Nomura M; Fujii M; Akamatsu H; Mizuno H; Tominaga H; Hasegawa J; Nakajima K; Yasumasa K; Yoshikawa M; Nishida T
    Surg Today; 2010 Mar; 40(3):234-8. PubMed ID: 20180076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of clinicopathological characteristics between colorectal signet-ring cell carcinoma and mucinous adenocarcinoma].
    Liu Q; Wang CF; Zhao DB; Gao JD; Bai XF; Xie YB
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(44):3124-6. PubMed ID: 21211342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
    Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.
    Pozos-Ochoa LI; Lino-Silva LS; León-Takahashi AM; Salcedo-Hernández RA
    Pathol Oncol Res; 2018 Jul; 24(3):609-616. PubMed ID: 28785968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
    Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
    Tsuta K; Ishii G; Nitadori J; Murata Y; Kodama T; Nagai K; Ochiai A
    J Pathol; 2006 May; 209(1):78-87. PubMed ID: 16463270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort.
    Nitsche U; Friess H; Agha A; Angele M; Eckel R; Heitland W; Jauch KW; Krenz D; Nüssler NC; Rau HG; Ruppert R; Schubert-Fritschle G; Wilhelm D; Werner J; Engel J
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2357-66. PubMed ID: 27573386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component.
    Wei Q; Wang X; Gao J; Li J; Li J; Qi C; Li Y; Li Z; Shen L
    PLoS One; 2016; 11(6):e0156659. PubMed ID: 27300552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers.
    Chew MH; Yeo SA; Ng ZP; Lim KH; Koh PK; Ng KH; Eu KW
    Int J Colorectal Dis; 2010 Oct; 25(10):1221-9. PubMed ID: 20686777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features of signet-ring cell carcinoma of the colon and rectum: a case-matched study.
    Min BS; Kim NK; Ko YT; Baek SH; Lee KY; Sohn SK; Cho CH; Kang DR
    Hepatogastroenterology; 2009; 56(93):984-8. PubMed ID: 19760925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization.
    Hayashi H; Kitamura H; Nakatani Y; Inayama Y; Ito T; Kitamura H
    Hum Pathol; 1999 Apr; 30(4):378-83. PubMed ID: 10208457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.
    Fang WL; Wu CW; Lo SS; Chen JH; Hsieh MC; Shen KH; Li AF; Tai LC; Lui WY
    Hepatogastroenterology; 2009; 56(93):1227-31. PubMed ID: 19760976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin.
    Sirintrapun SJ; Blackham AU; Russell G; Votanopoulos K; Stewart JH; Shen P; Levine EA; Geisinger KR; Bergman S
    Hum Pathol; 2014 Aug; 45(8):1597-604. PubMed ID: 24814804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does signet ring cell carcinoma component signify worse outcomes for patients with colorectal cancer?
    Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Kato T; Yamaguchi S
    Asian J Surg; 2021 Jan; 44(1):105-110. PubMed ID: 32295719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
    Wu X; Lin H; Li S
    BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucinous colorectal adenocarcinoma with signet-ring cells: immunohistochemical and ultrastructural study.
    Seretis E; Konstantinidou A; Arnogiannakis N; Xinopoulos D; Voloudakis-Baltatzis IE
    Ultrastruct Pathol; 2010 Dec; 34(6):337-43. PubMed ID: 21070165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological aspects of adenocarcinoma of the large bowel in a low incidence population.
    Dakubo JC; Naaeder SS; Gyasi RK
    J Surg Oncol; 2014 Mar; 109(3):245-9. PubMed ID: 24249202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.